Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation

v3.23.3
Stock-based Compensation
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation

Note 13 – Stock-based Compensation

 

The Company’s Amended and Restated 2013 Equity Compensation Plan (the “Plan”) provides for the granting of incentive stock options, nonqualified stock options, restricted stock units, performance units, and stock purchase rights. There were no significant modifications to the Plan during the nine month periods ended September 30, 2023 and 2022. The term of the Plan is for 10 years and will expire on May 7, 2024, if not amended before then.

 

The following table contains information about the Company’s stock plan at September 30, 2023:

 

  Awards
Reserved for
Issuance
    Awards
Issued &
Exercised
    Awards
Available
for Grant
 
2013 Equity Compensation Plan     54,294 *     37,915 **     16,379  

 

* Increased by 8,691 on January 1, 2023, representing 4% of the total number of shares of common stock outstanding on December 31, 2022.
** Includes both restricted stock grants and option grants

 

 

The Company recognized stock-based compensation expense (options and restricted share grants) in its condensed consolidated statements of operations as follows:

 

   

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
    2023     2022     2023     2022  
Research and Development   $ 507     $ 554     $ 1,576     $ 1,660  
General and Administrative     689       859       2,100       2,228  
Total   $ 1,196     $ 1,413     $ 3,676     $ 3,888  

 

As of September 30, 2023, total compensation costs related to unvested awards not yet recognized was $6,204 and the weighted-average periods over which the awards are expected to be recognized was 2.2 years.

 

Stock Options

 

The following table summarizes the activity for Company’ stock options for the nine months ended September 30, 2023:

 

    Stock Options  
Outstanding at December 31, 2022     34,739  
Granted     105  
Exercised      
Forfeited     (296 )
Expired     (1,314 )
Outstanding at September 30, 2023     33,234